Faculty

Paul K. Drain

Adjunct Associate Professor, Epidemiology
Associate Professor, Global Health

206-520-3820

Education

MD Medicine (MD), University of Washington, 2007
MPH Epidemiology and International Health, University of Washington, 2001
BA Microbiology, Miami University (Ohio), 1996

Contact

206-520-3820

Box 359927
325 Ninth Ave
Seattle, WA 98104
View Website »

Bio

Paul Drain’s research group focuses on development, evaluation and implementation of diagnostic testing and clinic-based screening, including novel point-of-care technologies, to improve clinical care and patient-centered outcomes for tuberculosis and HIV in resource-limited settings. He is the Director of Clinical and Translational Research at the International Center for Clinical Research (ICRC) and the Director of the Clinical and Translational Science Core within the Tuberculosis Research Advancement Center (SEA-TRAC) at the University of Washington. He currently teaches “Global Population Health” in the School of Public Health, and teaches “Clinical Global Health and Social Medicine” for medical students. He research has been supported by several institutes of the National Institutes of Health, the Infectious Disease Society of America, Bill and Melinda Gates Foundation, the US Centers for Disease Control and Prevention, the US Department of Defense, the NIH Center for AIDS Research, as well as several corporations. He has authored several global health books and received awards from the Global Health Education Consortium, the Infectious Disease Society of America, and a Faculty Teaching Award from Harvard Medical School. Paul completed his medicine training at Stanford University and his infectious disease training at Massachusetts General Hospital and Brigham and Women’s Hospital at Harvard Medical School in Boston.

Research Areas

Research Interests

  • Infectious diseases
  • Improve the diagnosis and treatment for tuberculosis, HIV, and HIV-related opportunistic infections

Research Group Website

Recent Publications (PubMed)

Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy.
(2024 Apr 15)
J Acquir Immune Defic Syndr 95(5): e8-e11
Dorward J, Sookrajh Y, Lessells R, Bulo E, Bodley N, Singh L, Moodley P, Samsunder N, Drain PK, Hayward G, Butler CC, Garrett N
Early HIV viral suppression associated with subsequent 12-month treatment success among people living with HIV in South Africa.
(2024 Mar 15)
HIV Med
Violette LR, Thomas KK, Dorward J, Quame-Amaglo J, Garrett N, Drain PK
Critical lessons from a pragmatic randomized trial of home-based COVID-19 testing in rural Native American and Latino communities.
(2024 Mar 6)
J Rural Health
Webber E, Bishop S, Drain PK, Dupuis V, Garza L, Gregor C, Hassell L, Ibarra G, Kessler L, Ko L, Lambert A, Lyon V, Rowe C, Singleton M, Thompson M, Warne T, Westbroek W, Adams A
The elusive allure of a rapid host blood signature for tuberculosis disease.
(2024 Feb 14)
J Clin Microbiol 62(2): e0128923
Drain PK, Dalmat RR
Correction: Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis.
(2024)
PLoS One 19(1): e0297828
Cantera JL, Lillis LM, Peck RB, Moreau E, Schouten JA, Davis P, Zheng RB, Lowary TL, Drain PK, Andama A, Pinter A, Kawasaki M, Källenius G, Sundling C, Dobos KM, Flores D, Chatterjee D, Murphy E, Halas OR, Boyle DS
Show complete publication list